Search
-
NewNatac positions itself among the world's growth companies
The company has been included in the World’s Growth Leaders ranking compiled by TIME magazine and Statista, which highlights the publicly traded companies with the strongest growth and financial
-
NewORYZON initiates patient enrollment in IDEAL Phase II trial of iadademstat in essential t...
Oryzon Genomics, a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the first patient has been enrolled in IDEAL, its Phase II study evaluating
-
NewBioClonal seeks strategic partnerships to advance its Alzheimer’s antibody program and ant...
Spanish biotechnology company BioClonal is advancing a proprietary monoclonal antibody program targeting a novel Alzheimer’s disease-related target and will leverage its participation at BIO
-
Press releaseThe combination of biotechnology, biomarkers and clinical research is driving a new era in...
Biotechnology is redefining the approach to multiple sclerosis through new therapeutic tools, a more precise understanding of the underlying immunological mechanisms, and strategies aimed not only at
-
NewWorld Multiple Sclerosis Day | “Biotechnology is enabling progress toward a better underst...
On the occasion of World Multiple Sclerosis Day, we interviewed Sanofi, which has a research line specifically focused on chronic neuroinflammation and its role in disease progression, seeking new
-
CompanyMICROSEI BIOTECH
-
NewThe Biotech Act drives the debate on the future of European biomedical innovation
From AseBio, we organized the panel entitled ‘European Biotechnology Act: an opportunity to consolidate Spain as a hub for biotechnological innovation’, within the framework of the XIX Annual
-
Press releaseThe Biotech Act drives the debate on the future of European biomedical innovation
From AseBio, we organized the panel entitled ‘European Biotechnology Act: an opportunity to consolidate Spain as a hub for biotechnological innovation’, within the framework of the XIX Annual
-
NewMedTech Barcelona to Attend BIO International Convention 2026 in San Diego
MedTech Barcelona will attend the BIO International Convention 2026, which will take place from June 22 to 25 at the San Diego Convention Center, in collaboration with ICEX. The company’s
-
NewBeyond Evidence: The Challenge of Communicating Value in Biotechnology
Spain is already generating science and innovation in biotechnology. The next challenge is not to produce more evidence, but to translate it into clear, decision-relevant value by connecting health
-
-
NewSimbionte relaunches its brand and service with Europe in its sights
The Valencia-based company, founded nearly four years ago, moves away from the content marketing agency model to launch a comprehensive digital go-to-market system designed specifically for B2B
-
NewMiramoon Pharma Wins Second Prize at ARVO 2026 Eye Pitch Competition
The startup receives $15,000 award for its innovative MP-004 therapy targeting retinitis pigmentosa.
-
NewDIVERSA Technologies launches Sphirence, a new technology platform for the cosmetic sector
The Spanish biotech company opens a new business line to apply its expertise in advanced lipid-based systems to the development of solutions for cosmetic ingredients.
-
NewBiolan presents a new innovative solution for the objective assessment of fish freshness
On May 21, the new BIOFISH 7000 TVBN device was unveiled in Lima as a world premiere, designed to measure fish freshness in an objective, fast, and simple way.
-
NewOpportunities in Healthy Aging
Rising life expectancy and increasing pressure on healthcare and social systems are driving a new market focused on prevention, independence, and quality of life for older adults.
-
NewBCN HEALTH Will present two communications at the Jornadas AES to be held in June in Sevil...
BCN HEALTH will participate in the Jornadas AES, which will take place in Seville from June 17 to 19.
-
NewPONS IP strengthens its Patent Department with a pioneering unit specialising in software,...
The new unit will be headed by Pablo Estebaranz Ruiz, an electronics engineer and European Patent Attorney (EPA)with over 18 years of experience.
-
NewNatac shortlisted for the Industry Awards in Spain for its commitment to industrial innova...
The company has been recognised for the European project SustaiNext and its DYANA technology, a pioneering intelligent biorefinery model based on the circular economy
-
NewMadrid Science Park celebrates its 25th anniversary consolidating its track record with 37...
Autónoma University of Madrid and Complutense University of Madrid founded the science incubator in 2001.
-
NewMSD Strengthens Its R&D Leadership in Spain: Up 8% From the Previous Year, Reaching 209 Cl...
The biomedical Company MSD, a leader in research, has reached a new milestone in its commitment to science and innovation in Spain.